Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

COVID-19 in Patients With Chronic Liver Diseases

ClinicalTrials.gov ID: NCT04439084

Public ClinicalTrials.gov record NCT04439084. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 7:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Study identification

NCT ID
NCT04439084
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Stanford University
Other
Enrollment
1,025 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2020
Primary completion
Jul 30, 2021
Completion
Jul 30, 2021
Last update posted
Aug 8, 2021

2020 – 2021

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
University of Arizona, Phoenix Arizona 85004
Mayo Clinic Scottsdale Arizona 85259
UCSF Fresno Fresno California 93701
University of Southern California Los Angeles California 90007
Stanford University Stanford California 94305
Georgetown University Washington D.C. District of Columbia 20057
VA Medical Center Washington D.C. District of Columbia 20422
University of Miami Miami Florida 33136
Rush University Medical Center Chicago Illinois 60612
The University of Kansas Medical Center Kansas City Kansas 66160
Oschner Medical Center Baton Rouge Louisiana 70816
Massachusetts General Hospital Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Ann Arbor Michigan 48109
Hennepin County Medical Center (HCMC) Minneapolis Minnesota 55415
University of Minnesota Minneapolis Minnesota 55455
Mount Sinai School of Medicine New York New York 10029
Weill Cornell Medicine New York New York 10065
Duke University Durham North Carolina 27710
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04439084, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2021 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04439084 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →